China Grants First-Ever Commercial Approval for Brain-Computer Implant

China's First Commercially Approved Neuroimplant

China's National Medical Products Administration (NMPA) has granted market authorization for the country's first invasive brain-computer interface (BCI), according to Bloomberg. The device, developed by Shanghai-based startup Neuracle Technology, is designed to help patients with paralysis partially regain control over hand movements.

The BCI system was tested on 36 patients during clinical trials. Participants demonstrated the ability to grasp and hold objects after implantation — a significant milestone for patients with spinal cord injuries who have retained some upper-arm functionality.

What the Neuracle System Includes

The Neuracle BCI is a comprehensive solution comprising multiple components:

• Sensors placed on the cerebral cortex;
• A robotic glove;
• Surgical instruments for implantation;
• A neural signal decoding algorithm;
• Software for verification and clinical use.

The product targets adult patients suffering from partial paralysis caused by spinal cord injuries. However, the implant is only suitable for individuals who have preserved certain functionality in the upper arm. This limitation stems from fewer channels and more restricted signal recognition capabilities compared to more advanced competitors.

Why This Matters

Bloomberg described the NMPA's decision as a major milestone for the rapidly expanding neurointerface market. Chinese startups are racing to commercialize BCI technology ahead of Western rivals, including Elon Musk's Neuralink, Synchron, Paradromics, and Merge Labs.

Beijing views brain-computer interfaces as a strategic high-tech priority. The Chinese government has been providing substantial support to BCI startups and aims to build a full-fledged industry in the coming years. Authorities have pledged to streamline regulatory review processes and introduce cost-reimbursement mechanisms to facilitate market entry.

Experts noted that the regulatory green light could accelerate development across the entire neurointerface sector.

BCI Technology and the Future of Human Intelligence

Brain implants are increasingly discussed not just as medical devices but as tools for cognitive enhancement. Tether CEO Paolo Ardoino has previously stated that humans will need to augment their intelligence through brain implants to remain relevant amid the rapid advancement of AI technologies.

China's first commercial BCI approval signals the transition of neurointerface technology from experimental stages to real-world market deployment. This shift could fundamentally reshape the landscape of medical rehabilitation and, potentially, human-computer interaction in the years ahead.